Hosting Organization
Operating Organization


Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

BIT Lifesciences, Inc.
Supporting Organization
International Marketing Partner

Participants List
(Academia)

National Yang-Ming University, Taiwan

Abyad Medical Center and Middle-East Longevity Institute, Lebanon

Akershus University Hospital, Norway

Aligarh M University, India

American University of Beirut, USA

Antwerp University Hospital, Belgium

Applied Proteomics and Molecular Medicine, USA

Aristotelian University of Thessaloniki, Greece

Banaras Hindu University, India

Barrow Neurological Institute, USA

Baylor College of Medicine, USA

Ben-Gurion University of the Negev, Israel

Boston University School of Medicine, USA

Cancer Research Technology, UK

CHDI Foundation, California

Chinese Academy of Sciences, China

CRG-Centre de Regulaci Genmica, Spain

CSIRO Molecular and Health Technologies, Australia

Duke University, USA

Emory University, USA

exas Southern University, USA

Florida A&M University, USA

Global Pathology Support, The Netherlands

Gujarat AIDS Awareness and Prevention Unit, India

Haematopoietic Stem Cell Laboratory, UK

Harvard Medical School, USA

Hospital S Hospital S Joao, Portugal

Human BioMolecular Re-. search Institute, USA

Indiana University School of Medicine, USA

Indiana University School of Medicine, USA

Innsbruck Medical University, Austria

Institute of Experimental Pharmacology, Slovak

Instituto De Biologia Experimentale Tecnologica, Portugal

Karolinska Institutet, Sweden

Keystone College Academia, USA

McGill University, Canada

Mercer University, USA

National Center for Toxicological Research, USA

National Institutes of Health, USA

Netherlands Cancer Institute, The Netherlands
New York Medical College, USA

Osaka University, Japan

Paul-Ehrlich-Institute, Germany

Penn State College of Medicine, USA

Pennsylvania State University College of Medicine, USA

Pharmacology Temple University, USA

Scientific Advisory Board Tolerx, USA 

Shanghai Unviversity of Traditional Chinese Medicine, China

Solid Tumor Working Party, Italy

Stanford University, USA

Structural Genomics Consortium Karolinska Institutet, Sweden

Tabriz University of Medical Sciences, Iran

Technion - Israel Institute of Technology Rappaport Institute, Israel

The Babraham Institute, UK

The Hebrew University, Israel

The Institute of Cancer Research, UK

The University of Queensland, Australia

The University of Sydney, Australia

The University of Texas, USA

UC College of Medicine, USA

Universidade Federal Fluminense, Brazil

University Clinic Bonn, Germany

University of Basel, Switzerland

University of British Columbia, Canada

University of California, USA

University of California-San Francisco, USA

University of Camerino, Italy

University of Cape Town, USA

University of Colorado Health Sciences Center, USA

University of Crete, Greece

University of Geneva, Switzerland

University of Heidelberg, Germany

University of Hong Kong, China

University of Maryland School of Pharmacy, USA

University of Maryland, USA

University of Massachusetts Medical School, USA

University of Miami School of Medicine, USA

University of Miami, USA

University of Miami, USA

University of Oklahoma Health Sciences Center, USA

University of Siena, Italy

University of Southern Denmark, Denmark

University of Texas at Dallas, USA

University of Texas Health Science Center, USA

University of Texas Medical, USA

University of the Sciences in Philadelphia, USA

University of Utah School of Medicine, USA

University of Western Australia, Australia

Utah State University, USA

Virginia Commonwealth University, USA

University of Gothenburg, Sweden


Participants List
(Business)

3 P Biopharmaceuticals, USA

Abbott Laboratories, USA

Adolor Corporation, USA

Affimed Therapeutics AG, Germany

AILERON Therapeutics, USA

Algorithme Pharma Inc., Canada

Allon Therapeutics Inc., USA

Alpha Cancer Technologies Inc., USA

Alpha-2 Pharmaceutica AB, Israel

Amgen, Inc., USA

Arena Pharmaceuticals, USA

Astellas Pharma Inc, Japan

Astellas Pharmaceutical Inc., Japan

AstraZeneca Pharmaceuticals, USA

AstraZeneca R&D Molndal, Sweden

Astrazeneca R&D Sodertolje, Sweden

AstraZeneca, UK

AstraZeneca, USA

AuxoCell Laboratories, Inc., USA

Avexa Ltd, Australia

Bayer HealthCare, USA

Bayer Schering Pharma AG, Germany

BellBrook Labs, LLC, USA

Biological Mimetics, Inc., USA

BioPerspectives, USA

Biota Holdings Limited, USA

Boehringer Ingelheim Pharmaceuticals, Inc., USA

Bristol-Myers Squibbs, USA

Centocor/Johnson & Johnson, USA

Chemistry Forma Therapeutics, Inc., Singapore

Coley Pharmaceutical GmbH, Germany

Cordex Pharma, Inc., USA

Cornerstone Pharmaceuticals, USA

Covidien, USA

Daiichi Sankyo Pharma Development, Japan

deCODE Chemistry, USA

DxS Ltd, USA

Eisai Co., Ltd., Japan

Elan Pharmaceuticals, USA

Europe GlaxoSmithKline R&D, UK

Genentech, USA

Genetix Ltd, UK

genscript, USA

Genzyme Pharmaceuticals, USA

Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA

Hoffmann-La Roche, Switzerland
ICON PLC, USA

IDDC Corporation, USA

Idera Pharmaceuticals, USA

Jesus College, England

Johnson & Johnson Pharmaceutical, USA

Johnson & Johnson Research Pty Limited, Australia

Laboratory Cellular Technology Ltd., USA

Lundbeck Research, USA

Mallinckrodt, Inc., USA

MDS Pharma Services, USA

Medimmune, UK

Merck & Co. Inc, USA

Merck & Co., Italy

Merck and Co., Inc., China

Merck KGaA, Germany

Merck Research Laboratories, USA

Nerviano Medical Sciences, Italy

Novartis Institutes for Biomedical Research, USA

Novartis Institutes, Switzerland

Novartis Pharmaceuticals Corporation, USA

Novartis, China

Ocimum Biosolutions, India

Ondokuz Mayis University, Turkey

OphthalmoPharma, Switzerland
Pfizer, USA

Pharmanet Development Group, Inc., USA

PharmaNet, Inc., USA

Ranbaxy Laboratories Limited, India

Reaction Biology Corporation, USA

RegPak BioPharma Consulting, The Netherlands

Sanofi Aventis, USA

Schering Plough Research Institute, USA

Schlich & Co, UK

Scott & White, USA

Sequoia Pharmaceuticals Inc., USA

SeraCare Life Sciences, USA

Shanghai Biochip Co., Ltd, China

Shenogen Pharma Group, China

Siena Biotech S.p.A. A company, USA

Simulations Plus, Inc., USA

Synta Pharmaceuticals Corp, USA

TEVA Pharmaceuticals, USA

The Takeda Oncology Company, USA

ThromboGenics, USA

Transgene, France

US Oncology Research, Inc., USA

Vaxinnate, USA

Wyeth Research, USA 

XOMA (US) LLC, USA

Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland

Zhejiang Hisun Pharmaceutical Co., Ltd, China

Tehran University of Medical Sciences , Iran


CMBF 2009
(Aug. 8-10, 2009, Dalian, China)
RMSC 2009
(Aug. 8-10, 2009, Dalian, China)
IDDST 2009
(Oct.22-25, 2009, Shanghai, China)
 
CEMD 2009
(Nov.19-21, 2009, Beijing, China)
WCG 2009
(December 1-7, 2009, Foshan, China)
 
ICC 2009
(Dec. 5-7, 2009, Shanghai, China)
Pepcon 2010
(March 21-23, 2010, Beijing, China)
ICA 2010
(March 24-26, 2010, Beijing, China)
WCV 2010
(March 24-26, 2010, Beijing, China)
SEB 2010
(Apr. 22-24, 2010, Shanghai, China)
WCC-Breast Cancer 2010
Tri-Breast Cancer Conference

(Apr. 25-27, 2010, Shanghai, China)
WCIT 2010
(May 15-18, 2010, Beijing, China)
ICM 2010
(May 18-20, 2010, Beijing, China)
WCCAS 2010
(May 19-21, 2010, Beijing, China )
IBIO 2010
(July 25-27, 2010, Qingdao, China)
WCVI-2010
(July 31-August 3, 2010, Korea)
 
  2009 Poster Abstracts

There will be an exhibition of posters at the conference and the abstracts of accepted posters will be published in the conference program. You will be notified if your abstract has been accepted for poster presentation as soon as it has been reviewed by the organizing committee. All accepted posters will be presented at Poster Viewing Session during the conference. Posters will be reviewed for oral presentation 4-6 weeks prior to the conference. Oral presenters will be notified via email or telephone at least 3 weeks before the conference. The selected presenters will be posted on the agenda.

Materials to hang your posters with will be available at the poster area. Set up time TBA. You will receive your poster number 4-6 weeks prior to the conference.

Your presence near it is kindly requested during lunches and coffee breaks for discussion.

Poster abstracts format
Posters will be judged during the conference. You are invited to submit an poster abstract on the following themes of the conference for presentation in poster format. Posters submitted should be based upon original / ongoing research. Abstracts should be submitted electronically, by 20 September 2009 to: sean@iddst.com

Abstracts must be submitted electronically. They should be in the following format:
Title in block capitals
Author (s) and principal affiliations, with the presenting author named first
Abstract text, of not more than 500 words, you may include the objective/purpose, method, results, and conclusion. Additionally the presenter should prepare some copies of the paper and name card, which can be distributed to the participants for keeping contact.
A list of references is optional (no more than 5)

Poster Instructions: Guidelines
The regular poster size is 70cm wide x 90cm high.
The text must be typed in single line spacing in black using less than 12 pitch character to ensure that the visitors can see clearly outside 1.5 meters.
You may display your poster from 22nd October to 24th October, 2009.

Posters’ hanging and taking down schedule
The Congress provides one board for each poster presenter, who should be aware that the poster installation and tear off are their own duties.

October 21

Morning

Afternoon

installation

 

17:00-18:00


October 22-24

Morning

Afternoon

installation

8:30-9:00

13:30-14:00

tear off

13:00-13:30

17:30-18:00

Presentation Topic:

1. Title program headings:
2. Diseases Clinical & Research
3. Epidemiology, Prevention and Diagnosis
4. New Technology & Approaches in Drug Discovery
5. Drug Discovery and Development
6. Biological Medicine
7. Patients Palliative Care and the Public
8. Enabling Infrastructure and Resources
Please fill out all fields. Maximum characters: 2500

Remark: For Poster Registration Only

1. If attending to our conference, the registration is for poster exhibition, not across to the other program, welcome banquet, meals and social event. The abstract of poster shall embody into the proceeding of conference; we shall provide the space for poster exhibition, excluding poster making.
2. If not attending to our conference, the abstract of poster shall embody into the proceeding of conference; we shall provide the space for poster exhibition, including poster making.

Please PRINT THE POSTER including the names of the authors and the title.

Abstract Title:
*
Authors:
*
Affiliations:
*
Presenting Author:
*
Phone:
*
Email:
* (Enter Correct E-mail Address)
Retype Email:
* (Retype Your Email Address)
Address:
*
City:
*
State:
*
Postal/Zip code:
*
Country:
*
Abstract:
*
Biography:
*